Cited by — Limited Impact of Adjuvant Chemotherapy in ALK-Positive Stage II–III Lung Adenocarcinoma: A Multicenter CReGYT-03 ALK Study | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Limited Impact of Adjuvant Chemotherapy in ALK-Positive Stage II–III Lung Adenocarcinoma: A Multicenter CReGYT-03 ALK Study.
No admitted local citation edges point to this work yet.
